Correlation of oxacillinase gene carriage with the genetic fingerprints of imipenem-resistant clinical isolates of Acinetobacter baumannii

Jundishapur Journal of Microbiology

Volumn 8, Issue 9, 2015, Pages

  Zanganeh, Zahra ^a   Eftekhar, Fereshteh ^a  

^a SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Acinetobacter baumannii; PCR; RAPD PCR

Indexed keywords

BETA LACTAMASE; IMIPENEM; OXACILLINASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; BURN; CONTROLLED STUDY; DNA FINGERPRINTING; GENETIC HETEROGENEITY; HETEROZYGOTE; IRAN; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXA 23 GENE; OXA 24 GENE; OXA 51 GENE; OXA 58 GENE; OXACILLINASE GENE; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA; SEQUENCE HOMOLOGY;

EID: 84942279823     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.26545     Document Type: Article

References (30)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter bauman- nii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;2l(3):538-82.
2. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254-63.
3. Manchanda V Sanchaita S, Singh N. Multidrug resistant acineto- bacter. J Glob Infect Dis. 2010;2(3):291-304.
4. Amudhan SM, Sekar U, Arunagiri K, Sekar B. OXA beta-lactamase- mediated carbapenem resistance in Acinetobacter baumannii. Indian J Med Microbiol. 2011;29(3):269-74.
5. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12(9):826-36.
6. Lu PL, Doumith M, Livermore DM, Chen TP, Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.JAntimicrob Chemother. 2009;63(4):641-7.
7. Yang HY, Lee HJ, Suh JT, Lee KM. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei Med J. 2009;50(6):764-70.
8. Merino M, Acosta J, Poza M, Sanz F, Beceiro A, Chaves F, et al. OXA- 24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother. 2010;54(6):2724-7.
9. Paton R, Miles RS, Hood J, Amyes SG, Miles RS, Amyes SG. ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. IntJ Antimicrob Agents. 1993;2(2):81-7.
10. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65(2):233-8.
11. DArezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multi-drug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother. 2011;66(1) 4-61.
12. Chen TL, Lee YT, Kuo SC, Hsueh PR, Chang FY, Siu LK, et al. Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acineto- bacter baumannii isolates in Taiwan. Antimicrob Agents Chemother. 2010;54(11):4575-81.
13. Clinical and Laboratory Standards Institute. Performance Stan-dards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement. Wayne, PA: CLSI; 2011.
14. Grundmann HJ, Towner KJ, Dijkshoorn L, Gerner-Smidt P, Ma-her M, Seifert H, et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol. 1997;35(12):3071-7.
15. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo- beta-lactamase and carbapenamase producing strains of Aci- netobacter baumannii from patients at Tehran hospitals. Iran J Microbiol. 2011;3(2):68-74.
16. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974-6.
17. Zander E, Nemec A, Seifert H, Higgins PG. Association between beta-lactamase-encoding bla(OXA-51) variants and DiversiLabrep-PCR-based typing of Acinetobacter baumannii isolates. Microbiol. 2012;50(6):1900-4.
18. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis. 2008;6l(4):274-8.
19. Lee YT, Kuo SC, Chiang MC, Yang SP, Chen CP, Chen TL, et al. Emergence of carbapenem-resistant non-baumannii species of Aci- netobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother. 2012;56(2):1124-7.
20. Vahaboglu H, Budak F, Kasap M, Gacar G, Torol S, Karadenizli A, et al. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother. 2006;58(3):537-42.
21. Kock MM, Bellomo AN, Storm N, Ehlers MM. Prevalence of car- bapenem resistance genes in Acinetobacter baumannii isolated from clinical specimens obtained from an academic hospital in South Africa: original research. South Afr J Epidemiol Infect. 2013;28(1):28-32.
22. Akbari M, Niakian M, Taherikalani M., Feizabadi MM, Azadi NA, Soroush S. Rapid identification of IranianAcinetobacter Bau- manniistrains by single PCR assay usingBLAoxa-51-like carbapen- emase and evaluation of the antimicrobial resistance profiles of the isolates. Acta Microbiol Immunol Hung. 2010;57(2):87-94.
23. Karmostaji A, Najar Peerayeh S, Hatef Salmanian A. Distribution of OXA-Type Class D p-Lactamase Genes Among Nosocomial Multi Drug Resistant Acinetobacter baumannii Isolated in Tehran Hospitals. JundishapurJMicrobiol. 2013;6(5):e8219.
24. Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Che-mother. 2007;5l(4):1530-3.
25. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemi-nation of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35-40.
26. Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD. Dissemination of multidrug-resistant Acineto- bacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2009;34(1):25-8.
27. Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of antibiotic resistance pattern in Acinetobacter bumannii car-rying bla oxA type genes isolated from hospitalized patients. Novelty Biomed. 2013;1(2):54-61.
28. Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosoco-mial strains in Poland. New Microbiol. 2012;35(3):317-25.
29. Sadeghifard N, Ranjbar R, Zaeimi J. Antimicrobial susceptibility, plasmid profiles, and RAPD-PCR typing of Acinetobacter bacteria. Asian Biomed. 2011;4(6):901-11.
30. Popova AV, Myakinina VP, Platonov ME, Volozhantsev NV. Mo-lecular genetic characterization of multidrug-resistant Acineto- bacter baumannii strains and assessment of their sensitivity to phage AP22. Mol Gen Microbiol Virol. 2012;27(4):154-9.